Add ANI As A Trusted Source For Reliable Information
Search For "casgevy"
Updated : 2 years, 5 months ago IST
The US Food and Drug Administration approved two gene therapies for the treatment of sickle cell disease (SCD) in patients aged 12 years and above.
Updated : 2 years, 6 months ago IST
After rigorous testing on safety, quality and effectiveness Britain's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised a world-first gene therapy, that will work to cure sickle-cell disease as well as B-thalassemia.